Danni Cao

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist”.

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist

Handbook of experimental pharmacology(2021)10.1007/164_2021_443

N/A

0DataRank · unranked

27 citations

Kevin B. Freeman, Vincent Setola, Danni Cao, Shane W Kaski, Mary Jeanne Kreek +2 more

Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects

Neuropharmacology(2021)10.1016/j.neuropharm.2021.108860

N/A

0DataRank · unranked

14 citations

Chongguang Chen, Danni Cao, Yingyu Huang, Lee‐Yuan Liu‐Chen, Peng Huang

Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4′-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors

Bioorganic Chemistry(2021)10.1016/j.bioorg.2021.104702

N/A

0DataRank · unranked

8 citations

Rama Gunta, Huiqun Wang, Mengchu Li, Danni Cao, Rolando E. Mendez +7 more

NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.123.001870

N/A

0DataRank · unranked

9 citations

Conrad K. Ho, Danni Cao, Saadet Inan, Scott M. Rawls, Mengchu Li +9 more